Response of high-sensitivity C-reactive protein to percutaneous coronary intervention in patients with acute coronary syndrome

被引:0
|
作者
Kyeong Ho Yun
Myung Ho Jeong
Seok Kyu Oh
Sang Jae Rhee
Eun Mi Park
Eun Mi Lee
Nam Jin Yoo
Nam-Ho Kim
Young Keun Ahn
Jin-Won Jeong
机构
[1] Wonkwang University Hospital,Department of Cardiovascular Medicine
[2] Chonnam National University Hospital,Department of Cardiovascular Medicine
来源
Heart and Vessels | 2009年 / 24卷
关键词
Percutaneous coronary angioplasty; Stent; C-reactive protein; Inflammation;
D O I
暂无
中图分类号
学科分类号
摘要
Percutaneous coronary intervention (PCI) provokes an inflammatory reaction, as shown by increased concentrations of plasma C-reactive protein (CRP) after PCI. However, the changes of CRP levels after PCI in patients with acute coronary syndrome (ACS) have not been well evaluated. We evaluated the characteristics of the patients with elevated CRP response after PCI and whether an increase in CRP after PCI predicts long-term prognosis in patients with ACS. We studied consecutive 360 patients with ACS who underwent elective coronary stenting. Inflammatory response to PCI was calculated as the difference between the peak postprocedural hsCRP level and the preprocedural hsCRP level (ΔCRP). Twelve months follow-up data were obtained and clinical outcomes were compared with ΔCRP. In receiver operating characteristics analyses, the cutoff point of ΔCRP for major adverse cardiac events (MACE) was 3.0 mg/l, which yielded sensitivity of 61.7% and specificity of 69.7%. The patients with ΔCRP > 3 mg/l revealed higher incidence of myocardial infarction (37.7 vs 14.6%, P < 0.001), and ACC/AHA type B2/C lesion (81.5 vs 68.7%, P = 0.006) than in patients with low ΔCRP. White blood cell count, low-density lipoprotein cholesterol, peak creatinine kinase-MB, and peak troponin T were significantly elevated in patients with ΔCRP > 3 mg/l than in those with ≤3 mg/l. There was significant correlation between ΔCRP and the changes in troponin T after PCI (r = 0.210, P < 0.001). An increase in hsCRP > 3 mg/l after PCI had a higher predictive value for the occurrence of MACE than low hsCRP elevation (hazard ratio 2.1, P = 0.005). In multivariate analysis, ΔCRP and peak troponin T were independent predictors of MACE (P < 0.001 and P = 0.013, respectively). In conclusion, postprocedural hsCRP elevation >3 mg/l was associated with higher incidence of MACE in patients with ACS. ΔCRP determinations may be of value for risk stratification after PCI.
引用
收藏
页码:175 / 180
页数:5
相关论文
共 50 条
  • [41] High-sensitivity C-reactive protein is quite low in Japanese men at high coronary risk
    Matsushita, Kunihiro
    Yatsuya, Hiroshi
    Tamakoshi, Koji
    Yang, Pei Ou
    Otsuka, Rei
    Wada, Keiko
    Mitsuhashi, Hirotsugu
    Hotta, Yo
    Kondo, Takahisa
    Murohara, Toyoaki
    Toyoshima, Hideaki
    CIRCULATION JOURNAL, 2007, 71 (06) : 820 - 825
  • [42] C-Reactive Protein and Inflammatory Cytokines during Percutaneous Coronary Intervention
    Wu, Mingxin
    Gu, Xinyuan
    Li, Xiujuan
    Li, Yanhui
    Zhou, Huaineng
    Lu, Guihua
    Wu, ZhongKai
    Huang, He
    Tang, Lilong
    Zeng, Jianping
    JOURNAL OF VASCULAR RESEARCH, 2016, 53 (1-2) : 39 - 48
  • [43] C-reactive protein and myocardial infarction during percutaneous coronary intervention
    Saleh, N
    Svane, B
    Velander, M
    Nilsson, T
    Hansson, LO
    Tornvall, P
    JOURNAL OF INTERNAL MEDICINE, 2004, 255 (01) : 33 - 39
  • [44] High-sensitivity C-reactive protein and coronary heart disease in a general population of Japanese - The Hisayama study
    Arima, Hisatomi
    Kubo, Michiaki
    Yonemoto, Koji
    Doi, Yasufumi
    Ninomiya, Toshiharu
    Tanizaki, Yumihiro
    Hata, Jun
    Matsumura, Kiyoshi
    Iida, Mitsuo
    Kiyohara, Yutaka
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2008, 28 (07) : 1385 - 1391
  • [45] C-reactive protein and coronary composition in patients with percutaneous revascularization
    Pucci, A.
    Brscic, E.
    Tessitore, E.
    Celeste, A.
    Crudelini, M.
    De Bernardi, A.
    Alberti, A.
    Biondi-Zoccai, G.
    Sheiban, I.
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2008, 38 (05) : 281 - 289
  • [46] Role of C-Reactive Protein in Determining Microvascular Function in Patients With Non-ST-Segment Elevation Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention
    Sezer, Murat
    Akdeniz, Cansu
    Aslanger, Emre
    Kaplan, Abdullah
    Yilmaz, Akar
    Guz, Goksel
    Umman, Berrin
    Bugra, Zehra
    Umman, Sabahattin
    AMERICAN JOURNAL OF CARDIOLOGY, 2013, 111 (12) : 1734 - 1738
  • [47] Interaction Between Cigarette Smoking and High-Sensitivity C-Reactive Protein in the Development of Coronary Vasospasm in Patients Without Hemodynamically Significant Coronary Artery Disease
    Hung, Ming-Yow
    Hsu, Kuang-Hung
    Hung, Ming-Jui
    Cheng, Chi-Wen
    Kuo, Li-Tang
    Cherng, Wen-Jin
    AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 2009, 338 (06) : 440 - 446
  • [48] High-sensitivity C-reactive protein and risk of clinical outcomes in patients with acute heart failure
    Santas, Enrique
    Villar, Sandra
    Palau, Patricia
    Llacer, Pau
    de la Espriella, Rafael
    Minana, Gema
    Lorenzo, Miguel
    Nunez-Marin, Gonzalo
    Gorriz, Jose Luis
    Carratala, Arturo
    Rodriguez, Enrique
    Bayes-Genis, Antoni
    Sanchis, Juan
    Nunez, Julio
    SCIENTIFIC REPORTS, 2024, 14 (01):
  • [49] Relationship of C-reactive protein to adverse cardiovascular events in patients treated by percutaneous coronary intervention for stable angina pectoris
    Veselka, J
    Prochazková, R
    Duchonová, R
    Homolová, I
    Tesar, D
    INTERNATIONAL HEART JOURNAL, 2005, 46 (02) : 195 - 204
  • [50] High-Sensitivity C-Reactive Protein and Statin Initiation
    Trpkovic, Andreja
    Stanimirovic, Julijana
    Rizzo, Manfredi
    Resanovic, Ivana
    Soskic, Sanja
    Jevremovic, Danimir
    Isenovic, Esma R.
    ANGIOLOGY, 2015, 66 (06) : 503 - 507